Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Return on Sales (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Return on Sales for 16 consecutive years, with 1.06% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 79.0% to 1.06% in Q4 2025 year-over-year; TTM through Nov 2025 was 0.22%, a 22.0% decrease, with the full-year FY2025 number at 0.22%, down 22.0% from a year prior.
  • Return on Sales was 1.06% for Q4 2025 at Cryo Cell International, down from 0.1% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.16% in Q2 2021 to a low of 2.14% in Q4 2023.
  • A 5-year average of 0.11% and a median of 0.08% in 2022 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: plummeted -225bps in 2023, then skyrocketed 187bps in 2024.
  • Cryo Cell International's Return on Sales stood at 0.09% in 2021, then surged by 224bps to 0.11% in 2022, then plummeted by -2083bps to 2.14% in 2023, then surged by 87bps to 0.27% in 2024, then plummeted by -291bps to 1.06% in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Return on Sales are 1.06% (Q4 2025), 0.1% (Q3 2025), and 0.04% (Q2 2025).